Track the 경동제약 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 경동제약 has logged 68 insider filings. Market capitalisation: €148.6bn. The latest transaction was disclosed on 14 July 2026 (Purchase). Among the most active insiders: 류덕희. Every trade is accessible without an account.
66
Insider Decl.
n/a
Thresholds
€3,540
61 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €3,540n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,584 of 29,156 companies
50.1
score / 100
Value
47
Quality
53
FCF yld-2.4%
Earn yld5.7%
EV/EBITDA13.3x
ROE·
Gross mgn60%
Net mgn4.3%
Debt/EBITDA3.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.